• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌的炎症发病机制。

The inflammatory pathogenesis of colorectal cancer.

机构信息

Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt/Main, Germany.

Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt/Main, Germany.

出版信息

Nat Rev Immunol. 2021 Oct;21(10):653-667. doi: 10.1038/s41577-021-00534-x. Epub 2021 Apr 28.

DOI:10.1038/s41577-021-00534-x
PMID:33911231
Abstract

The mutational landscape of colorectal cancer (CRC) does not enable predictions to be made about the survival of patients or their response to therapy. Instead, studying the polarization and activation profiles of immune cells and stromal cells in the tumour microenvironment has been shown to be more informative, thus making CRC a prototypical example of the importance of an inflammatory microenvironment for tumorigenesis. Here, we review our current understanding of how colon cancer cells interact with their microenvironment, comprised of immune cells, stromal cells and the intestinal microbiome, to suppress or escape immune responses and how inflammatory processes shape the immune pathogenesis of CRC.

摘要

结直肠癌(CRC)的突变景观不能用来预测患者的生存或对治疗的反应。相反,研究肿瘤微环境中免疫细胞和基质细胞的极化和激活状态已被证明更具信息量,因此使 CRC 成为炎症微环境对肿瘤发生重要性的典型范例。在这里,我们回顾了我们目前对结肠癌细胞如何与其微环境相互作用的理解,该微环境由免疫细胞、基质细胞和肠道微生物组组成,以抑制或逃避免疫反应,以及炎症过程如何塑造 CRC 的免疫发病机制。

相似文献

1
The inflammatory pathogenesis of colorectal cancer.结直肠癌的炎症发病机制。
Nat Rev Immunol. 2021 Oct;21(10):653-667. doi: 10.1038/s41577-021-00534-x. Epub 2021 Apr 28.
2
Role of epigenetics in transformation of inflammation into colorectal cancer.表观遗传学在炎症向结直肠癌转化中的作用。
World J Gastroenterol. 2019 Jun 21;25(23):2863-2877. doi: 10.3748/wjg.v25.i23.2863.
3
Metabolism and Colorectal Cancer.代谢与结直肠癌
Annu Rev Pathol. 2023 Jan 24;18:467-492. doi: 10.1146/annurev-pathmechdis-031521-041113. Epub 2022 Nov 2.
4
The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.肿瘤微环境细胞在结直肠癌(CRC)恶病质中的作用。
Int J Mol Sci. 2021 Feb 4;22(4):1565. doi: 10.3390/ijms22041565.
5
Intestinal inflammation and colorectal cancer: a double-edged sword?肠道炎症与结直肠癌:一把双刃剑?
World J Gastroenterol. 2011 Jul 14;17(26):3092-100. doi: 10.3748/wjg.v17.i26.3092.
6
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?间充质基质细胞(MSCs)与结直肠癌:抗肿瘤免疫反应中的一对麻烦搭档?
Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354.
7
Role of Gut Microbiome in Immune Regulation and Immune Checkpoint Therapy of Colorectal Cancer.肠道微生物群在结直肠癌免疫调节和免疫检查点治疗中的作用
Dig Dis Sci. 2023 Feb;68(2):370-379. doi: 10.1007/s10620-022-07689-0. Epub 2022 Dec 28.
8
Colorectal cancer mouse models: integrating inflammation and the stroma.结直肠癌小鼠模型:炎症与基质的整合。
J Gastroenterol Hepatol. 2012 Jan;27(1):39-50. doi: 10.1111/j.1440-1746.2011.06883.x.
9
CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer.CD90(+)基质细胞是白细胞介素-6的主要来源,白细胞介素-6可支持结直肠癌中的癌症干细胞并引发炎症。
Int J Cancer. 2016 Apr 15;138(8):1971-81. doi: 10.1002/ijc.29939. Epub 2015 Dec 10.
10
Interleukin-6 increases expression of serine protease inhibitor Kazal type 1 through STAT3 in colorectal adenocarcinoma.白细胞介素-6通过信号转导和转录激活因子3增加结直肠癌中Kazal型丝氨酸蛋白酶抑制剂1的表达。
Mol Carcinog. 2016 Dec;55(12):2010-2023. doi: 10.1002/mc.22447. Epub 2015 Dec 14.

引用本文的文献

1
Evaluation efficacy and accuracy of a real-time computer-aided polyp detection system during colonoscopy: a prospective, multicentric, randomized, parallel-controlled study trial.结肠镜检查期间实时计算机辅助息肉检测系统的评估效能与准确性:一项前瞻性、多中心、随机、平行对照研究试验。
Surg Endosc. 2025 Sep 2. doi: 10.1007/s00464-025-12080-x.
2
Identification and validation of the VEGF/p38MAPK/HSP27 pro-tumor inflammatory pathway: screening of active components from and evaluation of their drug-likeness.VEGF/p38丝裂原活化蛋白激酶/HSP27促肿瘤炎症通路的鉴定与验证:从……中筛选活性成分并评估其类药性
Front Immunol. 2025 Aug 14;16:1631031. doi: 10.3389/fimmu.2025.1631031. eCollection 2025.
3

本文引用的文献

1
Targeting metastatic cancer.针对转移性癌症。
Nat Med. 2021 Jan;27(1):34-44. doi: 10.1038/s41591-020-01195-4. Epub 2021 Jan 13.
2
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade.拮抗炎症表型决定肿瘤命运和对免疫检查点阻断的反应。
Immunity. 2020 Dec 15;53(6):1215-1229.e8. doi: 10.1016/j.immuni.2020.10.020. Epub 2020 Nov 20.
3
Immune scores in colorectal cancer: Where are we?结直肠癌的免疫评分:我们在哪里?
Tumor-associated macrophages in colon cancer immunotherapy: mechanisms, natural product interventions, and microenvironment remodeling.
结肠癌免疫治疗中的肿瘤相关巨噬细胞:作用机制、天然产物干预及微环境重塑
Front Immunol. 2025 Aug 12;16:1642091. doi: 10.3389/fimmu.2025.1642091. eCollection 2025.
4
The SPINK Protein Family in Cancer: Emerging Roles in Tumor Progression, Therapeutic Resistance, and Precision Oncology.癌症中的丝氨酸蛋白酶抑制剂Kazal型相关肽(SPINK)蛋白家族:在肿瘤进展、治疗抗性和精准肿瘤学中的新作用
Pharmaceuticals (Basel). 2025 Aug 13;18(8):1194. doi: 10.3390/ph18081194.
5
Metagenomic Signatures of Colorectal Cancer in the Jordanian Population: A Regional Case-Control Analysis Using 16S rRNA Profiling.约旦人群中结直肠癌的宏基因组特征:一项使用16S rRNA基因分型的区域病例对照分析。
Microorganisms. 2025 Aug 21;13(8):1963. doi: 10.3390/microorganisms13081963.
6
Inorganic Polyphosphate Triggers NLRP3 Inflammasome and Promotes the Epithelial-to-Mesenchymal Transition and Migration of Colorectal Cancer Cells Through TRPM8 Receptor.无机多聚磷酸盐通过TRPM8受体触发NLRP3炎性小体并促进结肠癌细胞的上皮-间质转化和迁移。
Int J Mol Sci. 2025 Aug 11;26(16):7743. doi: 10.3390/ijms26167743.
7
Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study.有无合并症的计算免疫标志物能否有效预测结直肠癌的生存率?一项纵向研究的结果
Med Sci (Basel). 2025 Aug 1;13(3):108. doi: 10.3390/medsci13030108.
8
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer.靶向巨噬细胞移动抑制因子作为结直肠癌的一种潜在治疗策略。
Oncogenesis. 2025 Aug 20;14(1):30. doi: 10.1038/s41389-025-00572-3.
9
Transcriptomic validation and clinical translation of CCDC78 as a prognostic biomarker in colorectal cancer.CCDC78作为结直肠癌预后生物标志物的转录组学验证及临床转化
Am J Cancer Res. 2025 Jul 25;15(7):3245-3266. doi: 10.62347/THYT9980. eCollection 2025.
10
It Is Time to Consider the Lost Battle of Microdamaged Piezo2 in the Context of and Early-Onset Colorectal Cancer.是时候在早期结直肠癌的背景下考虑微损伤Piezo2的败北了。
Int J Mol Sci. 2025 Jul 24;26(15):7160. doi: 10.3390/ijms26157160.
Eur J Cancer. 2020 Nov;140:105-118. doi: 10.1016/j.ejca.2020.08.024. Epub 2020 Oct 16.
4
The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis.中性粒细胞胞外诱捕网(NETs)在肿瘤进展和转移中的新兴作用。
Front Immunol. 2020 Sep 16;11:1749. doi: 10.3389/fimmu.2020.01749. eCollection 2020.
5
Host-microbiota maladaptation in colorectal cancer.结直肠癌中的宿主-微生物群失调。
Nature. 2020 Sep;585(7826):509-517. doi: 10.1038/s41586-020-2729-3. Epub 2020 Sep 23.
6
Integrated Omics of Metastatic Colorectal Cancer.转移性结直肠癌的综合组学研究
Cancer Cell. 2020 Nov 9;38(5):734-747.e9. doi: 10.1016/j.ccell.2020.08.002. Epub 2020 Sep 3.
7
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis.巨噬细胞形态与结直肠肝转移中单细胞多样性和预后相关。
J Exp Med. 2020 Nov 2;217(11). doi: 10.1084/jem.20191847.
8
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.肿瘤免疫微环境与免疫评分在癌症预后和治疗疗效中的作用
Nat Rev Cancer. 2020 Nov;20(11):662-680. doi: 10.1038/s41568-020-0285-7. Epub 2020 Aug 4.
9
AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer.AKT 依赖性 NOTCH3 激活驱动间充质型结直肠癌细胞模型中的肿瘤进展。
J Exp Med. 2020 Oct 5;217(10). doi: 10.1084/jem.20191515.
10
Microbiota-derived metabolite promotes HDAC3 activity in the gut.肠道微生物衍生代谢物促进 HDAC3 活性。
Nature. 2020 Oct;586(7827):108-112. doi: 10.1038/s41586-020-2604-2. Epub 2020 Jul 30.